drugset / Trial / NCT01542099

The EC50 of Remifentanil Blunting Hemodynamic Response to Double Lumen Tube Intubation

NCT01542099 ↗

Completed 80 enrolled Seoul National University Hospital
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to evaluate the effect site concentration of remifentanil blunting hemodynamic changes to tracheal intubation of single or double lumen tubes.

Timeline

Start
2011-11
Primary completion
2012-04
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Remifentanil Small molecule 6 ng/ml —

Indications

No indication recorded.